[1]
“Polypharmacy as a Major Determinant of Drug–Drug Interactions in Patients with Acute Myocardial Infarction: A Prospective Observational Study”, Pjmcr, vol. 4, no. 3, pp. 2701–2715, Apr. 2026, doi: 10.66021/pakmcr892.